[General considerations on asthma].
Asthma is an inflammatory illness of which the morbidity and mortality are on the increase. Its diagnosis is by clinical history, exploration of respiratory function, immuno-allergological investigation, skin tests and biological measurements that today are well-developed. Treatment of asthma must first fight the bronchial inflammation before a consideration of the etiological aspects. It uses inhaled corticosteroids (CSI), which is the step of etiological treatment, because of their good dose-efficacy properties. Bronchial penetration of CSI in an aerosol dose is often uncertain because of problems of hand-lung coordination. Beclojet 250, thanks to its Jet inhalation device, gives optimal broncho-pulmonary penetration.
Sabbah
A
A
Laboratoire d'Immuno-Allergologie, CHU, Angers, France.
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000328:Adult; D000336:Aerosols; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000150:complications / Q000235:genetics
D000305:Adrenal Cortex Hormones; D000336:Aerosols; D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents